Epitranscriptomic stabilization of chromatin reader ZMYND8 by the METTL14–YTHDF1 axis drives breast cancer progression

ZMYND8, a chromatin reader with dual histone and methylation recognition capacity, has been implicated in various cellular processes, yet the upstream regulatory mechanisms controlling ZMYND8 expression in breast cancer (BC) remain incompletely understood. Here, we demonstrate that ZMYND8 is markedly upregulated in BC tissues and selected cell lines. Functionally, genetic silencing of ZMYND8 inhibits cell proliferation, suppresses clonogenicity, induces apoptosis, and impairs migratory and invasive capabilities in BC cells. Mechanistically, we identify ZMYND8 mRNA as an m⁶A-modified transcript. Integrated analysis of TCGA-BRCA and experimental validation reveal that METTL14, an m⁶A methyltransferase, enhances ZMYND8 expression by promoting m⁶A modification and stabilizing its mRNA transcript. Moreover, the m⁶A reader YTHDF1 binds to methylated ZMYND8 mRNA in a METTL14-dependent manner and safeguards its stability. Collectively, our findings uncover a METTL14–YTHDF1–ZMYND8 regulatory axis that facilitates BC progression and highlight ZMYND8 as a potential epitranscriptomic effector in BC.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-16
DOI
https://doi.org/10.1007/s12672-026-06150-2
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epitranscriptomic stabilization of chromatin reader ZMYND8 by the METTL14–YTHDF1 axis drives breast cancer progression

Tao Yang, Yan Huang, Ruiti Tang, Lei Xiao et al.
1 links
Discover Oncology
RNA modifications and cancer
article

Epitranscriptomic stabilization of chromatin reader ZMYND8 by the METTL14–YTHDF1 axis drives breast cancer progression

Tao Yang, Yan Huang, Ruiti Tang, Lei Xiao, Jingya Yi, Ping Liu, Xiong Liu
article en

Abstract

ZMYND8, a chromatin reader with dual histone and methylation recognition capacity, has been implicated in various cellular processes, yet the upstream regulatory mechanisms controlling ZMYND8 expression in breast cancer (BC) remain incompletely understood. Here, we demonstrate that ZMYND8 is markedly upregulated in BC tissues and selected cell lines. Functionally, genetic silencing of ZMYND8 inhibits cell proliferation, suppresses clonogenicity, induces apoptosis, and impairs migratory and invasive capabilities in BC cells. Mechanistically, we identify ZMYND8 mRNA as an m⁶A-modified transcript. Integrated analysis of TCGA-BRCA and experimental validation reveal that METTL14, an m⁶A methyltransferase, enhances ZMYND8 expression by promoting m⁶A modification and stabilizing its mRNA transcript. Moreover, the m⁶A reader YTHDF1 binds to methylated ZMYND8 mRNA in a METTL14-dependent manner and safeguards its stability. Collectively, our findings uncover a METTL14–YTHDF1–ZMYND8 regulatory axis that facilitates BC progression and highlight ZMYND8 as a potential epitranscriptomic effector in BC.

Discover Oncology
Hunan Normal University (CN), Hunan Mawangdui Hospital (CN), Hunan Provincial People's Hospital (CN)
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon